Press Release: AZN INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO, Jan. 11, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of AstraZeneca PLC (NASDAQ: AZN) publicly traded securities between February 23, 2022 and December 17, 2024, inclusive (the “Class Period”), have until February 21, 2025 to seek appointment as lead plaintiff of…
Press Release: AZN INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Newscast
Mon, 21 Apr 2025 07:48:00 GMT SAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who ... On this news, the price of Manhattan Associates ...
Mon, 21 Apr 2025 07:48:00 GMT The Allegations: Robbins LLP is Investigating Allegations that Quantum Computing Inc. (QUBT) Misled Investors Regarding ... with false and misleading press releases, citing discussions with ...
Sun, 20 Apr 2025 17:00:00 GMT SAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Manhattan Associates ...
Fri, 18 Apr 2025 02:45:00 GMT On this news ... An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Semtech class action lawsuit. ABOUT ROBBINS GELLER: Robbins ...
Thu, 17 Apr 2025 04:39:00 GMT Caringal of Robbins ... this news, the price of Viatris common stock fell by more than 15%. THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor ...
